tiprankstipranks
Advertisement
Advertisement

IDYA Stock Latest News

IDEAYA Biosciences Shareholders Back Leadership, Governance Changes
Company AnnouncementsIDEAYA Biosciences Shareholders Back Leadership, Governance Changes
13d ago
8K
IDYA
Ideaya Advances IDE034 Into First-in-Human Trial for Advanced Solid Tumors
PremiumCompany Announcements
Ideaya Advances IDE034 Into First-in-Human Trial for Advanced Solid Tumors
19d ago
IDYA
Ideaya Biosciences elects CEO Yujiro Hata as chairman
PremiumThe Fly
Ideaya Biosciences elects CEO Yujiro Hata as chairman
20d ago
IDYA
Ideaya Biosciences enrolls first patient in IDE892 trial
PremiumThe Fly
Ideaya Biosciences enrolls first patient in IDE892 trial
22d ago
IDYA
IDEAYA Biosciences Raises $324 Million in Equity Offering
PremiumCompany Announcements
IDEAYA Biosciences Raises $324 Million in Equity Offering
26d ago
8K
IDYA
Ideaya Biosciences 5.56M share Spot Secondary priced at $27.00
PremiumThe FlyIdeaya Biosciences 5.56M share Spot Secondary priced at $27.00
28d ago
IDYA
Closing Bell Movers: Vail Resorts down 4% as earnings miss estimates
Premium
The Fly
Closing Bell Movers: Vail Resorts down 4% as earnings miss estimates
28d ago
AVO
MTN
Ideaya Biosciences $300M Spot Secondary re-offered at $27.00
Premium
The Fly
Ideaya Biosciences $300M Spot Secondary re-offered at $27.00
28d ago
IDYA
Ideaya Biosciences announces $300M common stock offering
PremiumThe Fly
Ideaya Biosciences announces $300M common stock offering
28d ago
IDYA
Analyst Reiterates Buy on IDEAYA, Citing Strong Oncology Pipeline and Partnerships with Unchanged $62 Price Target
PremiumRatings
Analyst Reiterates Buy on IDEAYA, Citing Strong Oncology Pipeline and Partnerships with Unchanged $62 Price Target
1M ago
IDYA
IDEAYA, Roche launch PRMT5 and pan-RAS collaboration
PremiumCompany Announcements
IDEAYA, Roche launch PRMT5 and pan-RAS collaboration
1M ago
8K
IDYA
Ideaya Biosciences announces IDE892 collaboration with Roche
PremiumThe Fly
Ideaya Biosciences announces IDE892 collaboration with Roche
1M ago
CHRO
IDYA
IDEAYA Highlights Positive Phase 2/3 Darovasertib Trial Results
PremiumCompany AnnouncementsIDEAYA Highlights Positive Phase 2/3 Darovasertib Trial Results
1M ago
8K
IDYA
Ideaya Biosciences, Servier present data from Phase 2/3 OptimUM-02 trial
Premium
The Fly
Ideaya Biosciences, Servier present data from Phase 2/3 OptimUM-02 trial
1M ago
IDYA
Ideaya Biosciences management to meet with Cantor
Premium
The Fly
Ideaya Biosciences management to meet with Cantor
1M ago
IDYA
Ideaya’s IDE574 Trial Signals New Optionality in Advanced Solid Tumors and Breast Cancer
PremiumCompany Announcements
Ideaya’s IDE574 Trial Signals New Optionality in Advanced Solid Tumors and Breast Cancer
2M ago
IDYA
Ideaya Biosciences price target lowered to $50 from $52 at Mizuho
PremiumThe Fly
Ideaya Biosciences price target lowered to $50 from $52 at Mizuho
2M ago
IDYA
IDEAYA Biosciences Files New Shelf Registration Statement
PremiumCompany Announcements
IDEAYA Biosciences Files New Shelf Registration Statement
2M ago
8K
IDYA
Ideaya Biosciences reports Q1 EPS ($1.11), consensus (98c)
PremiumThe Fly
Ideaya Biosciences reports Q1 EPS ($1.11), consensus (98c)
2M ago
IDYA
Ideaya Biosciences announces darovasertib combination NDA to be reviewed by FDA
PremiumThe FlyIdeaya Biosciences announces darovasertib combination NDA to be reviewed by FDA
2M ago
IDYA
Ideaya Biosciences price target raised to $58 from $52 at Wedbush
Premium
The Fly
Ideaya Biosciences price target raised to $58 from $52 at Wedbush
3M ago
IDYA
Ideaya Biosciences price target raised to $54 from $50 at Guggenheim
Premium
The Fly
Ideaya Biosciences price target raised to $54 from $50 at Guggenheim
3M ago
IDYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >